abstract |
The present invention describes a substance or a receptor comprising Helicobacter pylori binding oligosaccharide sequence [Gal(A) q (NAc) r /Glc(A) q (NAc) r α3/β3] s [Galβ4GlcNAcβ3] t Galβ4Glc(NAc) u wherein q, r, s, t, and u are each independently 0 or 1, and the use thereof in, e.g., pharmaceutical and nutritional compositions for the treatment of conditions due to the presence of Helicobacter pylori. The invention is also directed to the use of the receptor for diagnostics of Helicobacter pylori. |